Abstract
We thank Rosenberg et al. for their interest in our editorial1 on the potential role that anesthesiologists may have to play as genetic counselors in light of developments in the direct-to-consumer genetic testing market. We also appreciate these researchers noting the importance of malignant hyperthermia when discussing genetics in anesthesiology. The focus of the editorial was on pain genes; it was not meant to be comprehensive.

This publication has 2 references indexed in Scilit: